Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Tony van Werkhooven who wrote (1256)	3/6/1998 10:31:00 PM
From: Premier	Read Replies (2) \| Respond to of 2068

Tony: I have maintained all along that Oxford's PR is first rate. Market needs to see visible signs of improving fundamentals. IMHO, turnaround will take two quarters. Stock will eventually rebound. have we reached bottom? Thats the question. IMHO, market has discounted the financing issue. Stock will head south near term before an uptrend develops. This weakness should be viewed as buying opportunity. In line with AOL poster, one Yahoo poster stated that Oxford is offering brokers retention bonus. I did not understand how was bankruptcy risk removed by Price's involvement. Oxford did not get a penny from Price. If we assume that Price invested after dd therefore bankruptcy is not possible, such an assumption is blind faith in Price. Premier